Aneesa Sultan

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Pharmaceuticals (Basel, Switzerland)

Experimental biology and medicine (Maywood, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Touseef Rehan, Anum Tahir, Aneesa Sultan, Khulood Fahad Alabbosh, Shahid Waseem, Mazhar Ul-Islam, Khalid Ali Khan, Essam H Ibrahim, Muhammad Wajid Ullah, Nasrullah Shah
Mitigation of Benzene-Induced Haematotoxicity in Sprague Dawley Rats through Plant-Extract-Loaded Silica Nanobeads. Toxics 11 (10) (2023)
Muhammad Usman Tareen, Sana Riaz, Saima Shakil Malik, Sana Zahid, Anum Khursheed, Fizza Tariq, Faiza Abbas, Muhammad Nouman Malik, Riffat Aysha Anis, Mariam Anees, Iram Murtaza, Aneesa Sultan
CYP2C19*17 association with higher plasma 4-hydroxy tamoxifen in Pakistani (estrogen-positive) breast cancer patients. Experimental biology and medicine (Maywood, N.J.) (2023)
Muhammad Hamid Siddique, Sidra Bukhari, Inam Ullah Khan, Asiya Essa, Zain Ali, Usama Sabir, Omiya Ayoub, Haleema Saadia, Muhammad Yaseen, Aneesa Sultan, Iram Murtaza, Philip G Kerr, Mashooq Ahmad Bhat, Mariam Anees
In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Muhammad Hamid Siddique, Sidra Bukhari, Inam Ullah Khan, Asiya Essa, Zain Ali, Usama Sabir, Omiya Ayoub, Haleema Saadia, Muhammad Yaseen, Aneesa Sultan, Iram Murtaza, Philip G Kerr, Mashooq Ahmad Bhat, Mariam Anees
In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)